BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2972503)

  • 1. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
    Giosuè S; Parola D; Cafaggi R; Astengo D; Greco G; D'Onofrio V
    Clin Ter; 1987 Dec; 123(6):457-63. PubMed ID: 2972503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
    Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
    Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effectiveness of bamifylline in elderly patients with COPD].
    Cogo R; Monzani GP; Fusillo M; Vota M
    Minerva Med; 1991 Mar; 82(3):115-8. PubMed ID: 2006029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchodilators: theophylline derivatives].
    Neijens HJ
    Ned Tijdschr Geneeskd; 1986 Nov; 130(46):2068-71. PubMed ID: 3796739
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toxic dermatitis induced by bamifylline. 2 cases].
    Carsuzaa F; Schranz J
    Presse Med; 1993 Mar; 22(10):494. PubMed ID: 8511075
    [No Abstract]   [Full Text] [Related]  

  • 8. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 9. Theophylline: taking it to a new level.
    Messerschmidt K
    S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-functional study of the activity of a new xanthine derivative: bamifylline].
    Finiguerra M; Morandini GC
    Clin Ter; 1986 Jul; 118(2):125-35. PubMed ID: 3527540
    [No Abstract]   [Full Text] [Related]  

  • 12. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].
    Rabe KF; Dent G; Magnussen H
    Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421
    [No Abstract]   [Full Text] [Related]  

  • 14. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
    Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
    G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy trial: theophylline vs (dl) 3,7-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1H-purine-2,6-dione.
    Grassi C; Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):518-22. PubMed ID: 7014478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Why is Etaphylline not better in chronic aspecific respiratory disease?].
    Zuidema J; Merkus FW
    Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1527-8. PubMed ID: 492369
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
    Oren R; Beeri M; Hubert A; Kramer MR; Matzner Y
    Arch Intern Med; 1997 Jul; 157(13):1474-8. PubMed ID: 9224226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis.
    Cogo R; Castronuovo A
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):15-20. PubMed ID: 11409184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A bronchodilator and spasmolytic of a new formula: AC 3810 (trentadil). Clinical trial and comparison with theophylline].
    de Lostalot J
    J Med Bord; 1967 Apr; 144(4):596-602. PubMed ID: 5611089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.